Le Lézard
Classified in: Science and technology, Business
Subject: SHA

Notification according to Chapter 9,Section10 of the Finnish Securities Markets Act of change in holdings in Caverion Corporation shares:Antti Herlin, Security Trading and Hisra Consulting and Finance Oy


HELSINKI, Oct. 26, 2023 /PRNewswire/ -- Caverion Corporation has on 25 October 2023 received an announcement under Chapter 9, Section 5 of the Finnish Securities Markets Act, according to which the holding of Antti Herlin, Security Trading Oy and Hisra Consulting and Finance Oy has decreased below the threshold of 5 percent. According to the announcement, the holding decreased below the threshold on 24 October 2023.

According to the announcement, the direct holding of Antti Herlin, Security Trading Oy and Hisra Consulting and Finance Oy in Caverion will decrease to 0 shares, corresponding to 0.00 percent of Caverion's shares and voting rights. The announced decrease in shareholding is based on share disposals, which upon completion result in the direct holding of Antti Herlin, Security Trading Oy and Hisra Consulting and Finance Oy to decrease below the 5 percent threshold in the manner provided for in Chapter 9, Section 5 of the SMA, and such share disposals are expected to be completed on or about 31 October 2023. Caverion's registered total number of shares amounting to 138,920,092 has been used in the calculation of percentages for the announcement.

Total positions of person(s) subject to the notification:


% of shares and
voting rights
 

% of shares and voting
rights through financial
instruments
 

Total of both in % 

Total number of  shares
and voting rights of issuer

Resulting situation on the
date on which threshold
was crossed or reached

0.00 %

0.00

0.00 %

138,920,092

Position of previous notification
(if applicable)

15.1558 %


15.1558 %


 

Notified details of the resulting situation on the date on which the threshold was crossed:

A: Shares and voting rights:

Class/type of shares

Number of shares
and voting rights 

% of shares and
voting rights


Direct 
(SMA 9:5)

Indirect
(SMA 9:6 and 9:7)

Direct 
(SMA 9:5)

Indirect
(SMA 9:6 and 9:7)

FI4000062781

0.00

0.00

0.00

0.00

SUBTOTAL A

0.00

0.00

B: Financial instruments according to SMA 9:6a:

Type of
financial
instrument

Expiration date

Exercise/
Conversion
Period

Physical or
cash settlement

Number of
shares and
voting rights

% of shares and
voting rights

N/A

N/A

N/A

N/A

N/A

N/A


SUBTOTAL B

N/A

N/A

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:

Name

% of shares and
voting rights

% of shares and
voting rights through
financial instruments

Total of both

Antti Herlin

0.00

0.00

0.00

Security Trading Oy

0.00

0.00

0.00

Hisra Consulting and Finance Oy

0.00

0.00

0.00

 

CAVERION CORPORATION

Distribution: Nasdaq Helsinki, principal media, www.caverion.com  

CONTACT:

For further information:

Noora Koikkalainen, Head of Investor Relations, tel. +358 50 562 6552, [email protected] 

 

The following files are available for download:

https://mb.cision.com/Main/14078/3862175/2387512.pdf

Release


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: